ArticleCancer science2023

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.

Chihiro Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.